Lidoposterin Kade

Lidocaine, the active ingredient in Lidoposterin Kade, is a local anesthetic presented as a rectal preparation for local anesthesia use. It provides reversible nerve block to reduce pain sensation during minor rectal procedures and diagnostic examinations or therapeutic interventions in clinical settings while facilitating procedural efficiency and improving patient comfort.

GNH USA supplies Lidoposterin Kade as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics, and pharmacies worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global healthcare providers.

Lidoposterin Kade, a local anesthetic, is employed to achieve temporary loss of sensation in the rectal mucosa for various procedures.

- Hemorrhoidectomy: provides localized anesthesia to reduce procedural pain. - Anal fissure treatment: numbs the affected area to facilitate conservative management. - Endoscopic rectal examination: ensures patient comfort during diagnostic scopes. - Minor rectal surgeries: offers rapid onset analgesia for short‑duration interventions. - Proctologic biopsies: enables painless tissue sampling.

Lidoposterin Kade may cause a range of adverse reactions following rectal administration.

Common Side Effects: - Burning or stinging at the application site - Local itching or erythema - Mild dizziness or light‑headedness - Nausea or mild gastrointestinal discomfort - Transient headache - Temporary numbness extending beyond the intended area

Serious or Rare Side Effects: - Seizures or convulsions - Cardiac arrhythmias, including ventricular tachycardia - Respiratory depression or apnea - Methemoglobinemia - Severe allergic reactions such as anaphylaxis - Persistent numbness or paresthesia lasting beyond the expected duration

Prior to using Lidoposterin Kade, consider the following safety measures.

- Allergy assessment: verify no known hypersensitivity to lidocaine or amide‑type anesthetics. - Cardiac history: caution in patients with conduction disorders or recent myocardial infarction. - Liver function: adjust use in severe hepatic impairment due to altered metabolism. - Dosage limits: adhere strictly to prescribed amount to avoid systemic toxicity. - Concomitant CNS depressants: monitor for additive central nervous system effects. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lidoposterin Kade can interact with other medications, influencing its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may markedly increase plasma lidocaine levels. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): can reduce lidocaine metabolism.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance lidocaine's cardiac depressant effects. - Other local anesthetics: concurrent use can raise risk of systemic toxicity. - Diuretics (e.g., furosemide): may lower serum potassium, predisposing to arrhythmias. - Anticonvulsants: monitor for additive CNS effects.